Intraductal Papillary Mucinous Neoplasm With Malignant Change

NCT02044926 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 54

Last updated 2016-07-22

No results posted yet for this study

Summary

Purpose:

To investigate diagnostic performance of CT and MR in intraductal papillary mucinous neoplasm with malignant change according to international consensus guidelines 2012.

Hypothesis: According to 2012 consensus guidelines, enhanced solid component and main pancreatic duct size of larger than 10 mm will be significant.

Conditions

  • IPMN

Sponsors & Collaborators

  • Asan Medical Center

    lead OTHER

Principal Investigators

  • Jae Ho Byun · Asan Medical Center

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2016-05-31
Completion
2016-07-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02044926 on ClinicalTrials.gov